Plasma resilience: Europe’s lifeline — and why we must strengthen it now

When we think of medical breakthroughs, we rarely think of medicines made from human plasma. However, this golden, protein-rich liquid — accounting for 55% of our blood — is essential for the development of therapies for countless conditions, from rare inherited disorders to immunodeficiencies.